Andean Precious Metals (CVE:APM) Trading 7.5% Higher – Here’s What Happened

Andean Precious Metals Corp. (CVE:APM) rose 7.5% during trading on Thursday . The company traded as high as C$1.29 and last traded at C$1.29. Approximately 225,691 shares were traded during trading, an increase of 41% from the average daily volume of 159,585 shares. The stock had previously closed at C$1.20.

Analyst Upgrades and Downgrades

Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.

Andean Precious Metals Price Performance

The company has a market capitalization of C$192.67 million, a P/E ratio of 3.39 and a beta of 1.22. The business has a 50-day moving average of C$1.28 and a 200-day moving average of C$1.30.

Andean Precious Metals (CVE:APM) last issued its quarterly earnings results on Monday, November 11th. The company reported C$0.07 earnings per share (EPS) for the quarter. Andean Precious Metals had a return on equity of 41.08% and a net margin of 23.75%. Sell-side analysts predict that Andean Precious Metals Corp. will post 0.3806452 EPS for the current fiscal year.

Insider Buying and Selling

In other Andean Precious Metals news, Senior Officer Juan Carlos Sandoval Amare bought 31,300 shares of Andean Precious Metals stock in a transaction on Friday, January 3rd. The shares were acquired at an average price of C$1.21 per share, for a total transaction of C$37,860.48. 69.37% of the stock is owned by corporate insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.